Heron Therapeutics, Inc. (HRTX)
0.3476
-0.01
(-2.33%)
USD |
NASDAQ |
Oct 02, 16:00
0.372
+0.02
(+7.02%)
After-Hours: 20:00
Heron Therapeutics Net Income (Quarterly) : -5.489M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.489M |
| March 31, 2026 | -8.111M |
| December 31, 2025 | -2.954M |
| September 30, 2025 | -17.50M |
| June 30, 2025 | -2.381M |
| March 31, 2025 | 2.635M |
| December 31, 2024 | 3.663M |
| September 30, 2024 | -4.848M |
| June 30, 2024 | -9.235M |
| March 31, 2024 | -3.16M |
| December 31, 2023 | -10.72M |
| September 30, 2023 | -25.01M |
| June 30, 2023 | -42.06M |
| March 31, 2023 | -32.77M |
| December 31, 2022 | -19.87M |
| September 30, 2022 | -41.91M |
| June 30, 2022 | -56.36M |
| March 31, 2022 | -63.89M |
| December 31, 2021 | -54.65M |
| September 30, 2021 | -52.41M |
| June 30, 2021 | -61.02M |
| March 31, 2021 | -52.61M |
| December 31, 2020 | -62.28M |
| September 30, 2020 | -58.23M |
| June 30, 2020 | -55.19M |
| Date | Value |
|---|---|
| March 31, 2020 | -51.58M |
| December 31, 2019 | -57.92M |
| September 30, 2019 | -33.60M |
| June 30, 2019 | -50.22M |
| March 31, 2019 | -63.01M |
| December 31, 2018 | -49.56M |
| September 30, 2018 | -38.35M |
| June 30, 2018 | -38.67M |
| March 31, 2018 | -52.26M |
| December 31, 2017 | -62.49M |
| September 30, 2017 | -41.87M |
| June 30, 2017 | -42.80M |
| March 31, 2017 | -50.33M |
| December 31, 2016 | -47.96M |
| September 30, 2016 | -48.51M |
| June 30, 2016 | -43.23M |
| March 31, 2016 | -33.44M |
| December 31, 2015 | -31.24M |
| September 30, 2015 | -22.67M |
| June 30, 2015 | -23.11M |
| March 31, 2015 | -20.57M |
| December 31, 2014 | -20.62M |
| September 30, 2014 | -19.19M |
| June 30, 2014 | -19.01M |
| March 31, 2014 | -17.54M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -40.55M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 37.67M |
| Total Expenses (Quarterly) | 43.16M |
| EPS Diluted (Quarterly) | -0.0288 |
| Enterprise Value | 172.60M |
| Gross Profit Margin (Quarterly) | 69.28% |
| Profit Margin (Quarterly) | -14.57% |
| Earnings Yield | -54.66% |
| Normalized Earnings Yield | -40.91 |